New Ciox Health and HealthVerity Partnership Utilizes COVID-19 RWD

Ciox Health and HealthVerity will partner to conduct a unique clinical trial using RWD (real world data). One source of the RWD will be deidentified COVID-19 vaccine clinical trial data. The use of RWD and RWE (real world evidence) could improve clinical trial efficiency while reducing costs.

According to HealthVerity CEO and Co-Founder Andrew Kress, “This innovation in real-world data detection and delivery gives prospective interventional and observational trials researchers a new tool for evidence generation that is faster and more efficient than previous methods,” adding, “We remain committed to frictionless real-world data intelligence, particularly in this time of urgent need to quickly advance COVID-19 vaccines.” Learn more here.

(Source: Cision PR Newswire, 2/10/21)